search
Back to results

Prevalence of Intrauterine Adhesions After D&C With or Without Antiadhesion Gel After Abortion in Second Trimester. (ADAB)

Primary Purpose

Asherman Syndrome, Abortion Late

Status
Unknown status
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Hyaluronic Acid 20 MG/ML Injectable Solution
Dilation and curretage
Sponsored by
Institute for the Care of Mother and Child, Prague, Czech Republic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Asherman Syndrome focused on measuring Asherman Syndrome, Abortion Late, Hyaluronic acid gel, Hysteroscopy

Eligibility Criteria

18 Years - 40 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Adult (18 to 40 years) women with a wish for future pregnancy
  • abortion in the 2nd trimester of pregnancy (over 12 weeks of pregnancy) with instrumental revision of the uterine cavity (RCUI)
  • signed informed consent

Exclusion Criteria:

  • age below 18 years, age over 40 years
  • history of previous uterine surgery (myomectomy, resection of the intrauterine septum, disruption of intrauterine adhesions)
  • suspected molar pregnancy
  • signs of pelvic infection
  • disagreement with participation in the study

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    Hyaluronic acid gel after D&C

    Only D&C

    Arm Description

    After abortion in the II trimester, we provide D&C and after the procedure, we apply in uterine cavity Hyaluronic acid gel.

    After abortion, in the II trimester, we provide only D&C.

    Outcomes

    Primary Outcome Measures

    Prevalence of Intrauterine adhesions after D&C and intrauterine application of hyaluronic acid gell.
    To find out wheter the application of antiadhesive agent with hyaluronic acid has an effect on the frequency of intrauterine adhesions after this procedure.
    Prevalence of Intrauterine adhesions after D&C.
    Dermination of the frequency of intrauterine adhesions in women who underwent instrumental revision of the uterine cavity (RCUI, revisio cavi uteri instrumentalis) after abortion in the 2nd trimester of pregnancy

    Secondary Outcome Measures

    Pregnancy rate
    Number of pregnancies (pregnancy rate) in the period of 24 months after RCUI in both groups
    Delivery rate
    Number of term deliveries in the 24 months after RCUI in both groups

    Full Information

    First Posted
    December 10, 2020
    Last Updated
    January 12, 2021
    Sponsor
    Institute for the Care of Mother and Child, Prague, Czech Republic
    Collaborators
    Bulovka Hospital, General University Hospital, Prague
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04671914
    Brief Title
    Prevalence of Intrauterine Adhesions After D&C With or Without Antiadhesion Gel After Abortion in Second Trimester.
    Acronym
    ADAB
    Official Title
    Prevalence of Intrauterine Adhesions After the Application of Hyaluronic Acid Gel After Dilatation and Curettage in Women With Spontaneous Abortion or Induction of Abortion From 12+0 Till 23+6 Week of Pregnancy.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    January 2021
    Overall Recruitment Status
    Unknown status
    Study Start Date
    February 1, 2021 (Anticipated)
    Primary Completion Date
    December 31, 2022 (Anticipated)
    Study Completion Date
    June 1, 2023 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Institute for the Care of Mother and Child, Prague, Czech Republic
    Collaborators
    Bulovka Hospital, General University Hospital, Prague

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Only patients who sign an informed consent will be included. Patients after a miscarriage in the 2nd trimester of pregnancy who need to perform an instrumental revision of the uterine cavity (RCUI, revisio cavi uteri instrumentalis) will be randomized into two groups. In the first group, RCUI will be performed according to current standards. In the second group, an anti-adhesive preparation with hyaluronic acid (Hyalobarrier gel Endo) will be applied to the uterine cavity at the end of the RCUI procedure. Eight to twelve weeks after the operation, the occurrence of adhesions will be evaluated by ultrasound examination and diagnostic hysteroscopy (if adhesions will be detected, they will be disrupted). The study will also include the completion of a questionnaire in terms of the frequency and strength of the menstrual cycle. The presence of adhesions will be assessed according to The American Fertility Society (AFS).
    Detailed Description
    Methodology Only patients who sign informed consent will be included. Patients after a miscarriage in the 2nd trimester of pregnancy who need to perform an instrumental revision of the uterine cavity (RCUI, revisio cavi uteri instrumentalis) will be randomized into two groups. In the first group, RCUI will be performed according to current standards. In the second group, an anti-adhesive preparation with hyaluronic acid (Hyalobarrier gel Endo) will be applied to the uterine cavity at the end of the RCUI procedure. Eight to twelve weeks after the operation, the occurrence of adhesions will be evaluated by ultrasound examination and diagnostic hysteroscopy (if adhesions will be detected, they will be disrupted). The study will also include the completion of a questionnaire in terms of the frequency and strength of the menstrual cycle. The presence of adhesions will be assessed according to The American Fertility Society (AFS). Expected number of enrolled subjects: a total of 200 patients, 100 in each branch Entry criteria: Adult (18 to 40 years old) women with a wish for future pregnancy, abortion in the 2nd trimester of pregnancy (over 12 weeks of pregnancy) with instrumental revision of the uterine cavity (RCUI), signed informed consent Exclusion criteria: age below 18 years, age over 40 years, history of previous uterine surgery (myomectomy, resection of the intrauterine septum, disruption of intrauterine adhesions), suspicion of molar pregnancy, signs of pelvic infection, disagreement with participation in the study Primary goals of the project: determination of the frequency of intrauterine adhesions in women who underwent instrumental revision of the uterine cavity (RCUI, revisio cavi uteri instrumentalis) after abortion in the 2nd trimester of pregnancy to determine whether the application of an antiadhesive agent with hyaluronic acid has an effect on the frequency of intrauterine adhesions after this procedure A similar prospective randomized multicenter study investigating the relationship of intrauterine adhesions using an intrauterine gel with hyaluronic acid was published in 2017 by Hooker. Patients were enrolled in the study up to the 14th week of pregnancy. The incidence of intrauterine adhesions was statistically lower in the hyaluronic acid group compared to the no treatment group (13% vs. 30.6%, RR 0.43, 95% CI 0.22-0.83, p 0.013). However, this study investigated RCUI in the first trimester of pregnancy. Our study is to our knowledge the first with a focus on the second trimester RCUI. Secondary goals of the project: number of pregnancies (pregnancy rate) in the period of 24 months after RCUI in both groups number of term pregnancies in the 24 months after RCUI in both groups

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Asherman Syndrome, Abortion Late
    Keywords
    Asherman Syndrome, Abortion Late, Hyaluronic acid gel, Hysteroscopy

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Phase 4
    Interventional Study Model
    Parallel Assignment
    Model Description
    Multicenter prospective controlled study
    Masking
    ParticipantInvestigator
    Masking Description
    Participant will not be informed about usage of hyalobarier gel or not. Care provider - at the time of RCUI the surgeon will know from randomisation if apply the gel or not. The investigator performing evaluation of adhesions by hysteroscopy will be blinded to the arm which the participants belong to.
    Allocation
    Randomized
    Enrollment
    200 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Hyaluronic acid gel after D&C
    Arm Type
    Active Comparator
    Arm Description
    After abortion in the II trimester, we provide D&C and after the procedure, we apply in uterine cavity Hyaluronic acid gel.
    Arm Title
    Only D&C
    Arm Type
    Active Comparator
    Arm Description
    After abortion, in the II trimester, we provide only D&C.
    Intervention Type
    Drug
    Intervention Name(s)
    Hyaluronic Acid 20 MG/ML Injectable Solution
    Intervention Description
    Application of hyaluronic acid gel into uterine cavity after After abortion in II trimester we do D&C
    Intervention Type
    Other
    Intervention Name(s)
    Dilation and curretage
    Intervention Description
    After abortion in II trimester we do D&C.
    Primary Outcome Measure Information:
    Title
    Prevalence of Intrauterine adhesions after D&C and intrauterine application of hyaluronic acid gell.
    Description
    To find out wheter the application of antiadhesive agent with hyaluronic acid has an effect on the frequency of intrauterine adhesions after this procedure.
    Time Frame
    3 month
    Title
    Prevalence of Intrauterine adhesions after D&C.
    Description
    Dermination of the frequency of intrauterine adhesions in women who underwent instrumental revision of the uterine cavity (RCUI, revisio cavi uteri instrumentalis) after abortion in the 2nd trimester of pregnancy
    Time Frame
    3 month
    Secondary Outcome Measure Information:
    Title
    Pregnancy rate
    Description
    Number of pregnancies (pregnancy rate) in the period of 24 months after RCUI in both groups
    Time Frame
    24 month
    Title
    Delivery rate
    Description
    Number of term deliveries in the 24 months after RCUI in both groups
    Time Frame
    24 month

    10. Eligibility

    Sex
    Female
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    40 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Adult (18 to 40 years) women with a wish for future pregnancy abortion in the 2nd trimester of pregnancy (over 12 weeks of pregnancy) with instrumental revision of the uterine cavity (RCUI) signed informed consent Exclusion Criteria: age below 18 years, age over 40 years history of previous uterine surgery (myomectomy, resection of the intrauterine septum, disruption of intrauterine adhesions) suspected molar pregnancy signs of pelvic infection disagreement with participation in the study
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Jiri Hanacek, MD, Ph.D.
    Phone
    +420604154736
    Email
    jiri.hanacek@upmd.eu

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    12620443
    Citation
    Wang X, Chen C, Wang L, Chen D, Guang W, French J. Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study. Fertil Steril. 2003 Mar;79(3):577-84. doi: 10.1016/s0015-0282(02)04694-0.
    Results Reference
    result
    PubMed Identifier
    16905025
    Citation
    Rai R, Regan L. Recurrent miscarriage. Lancet. 2006 Aug 12;368(9535):601-11. doi: 10.1016/S0140-6736(06)69204-0.
    Results Reference
    result
    PubMed Identifier
    18902559
    Citation
    ASHERMAN JG. Amenorrhoea traumatica (atretica). J Obstet Gynaecol Br Emp. 1948 Feb;55(1):23-30. doi: 10.1111/j.1471-0528.1948.tb07045.x. No abstract available.
    Results Reference
    result
    PubMed Identifier
    28390688
    Citation
    Hooker AB, de Leeuw R, van de Ven PM, Bakkum EA, Thurkow AL, Vogel NEA, van Vliet HAAM, Bongers MY, Emanuel MH, Verdonkschot AEM, Brolmann HAM, Huirne JAF. Prevalence of intrauterine adhesions after the application of hyaluronic acid gel after dilatation and curettage in women with at least one previous curettage: short-term outcomes of a multicenter, prospective randomized controlled trial. Fertil Steril. 2017 May;107(5):1223-1231.e3. doi: 10.1016/j.fertnstert.2017.02.113. Epub 2017 Apr 6.
    Results Reference
    result

    Learn more about this trial

    Prevalence of Intrauterine Adhesions After D&C With or Without Antiadhesion Gel After Abortion in Second Trimester.

    We'll reach out to this number within 24 hrs